Tytuł pozycji:
Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis
-
Tytuł:
-
Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis
-
Autorzy:
-
Langley, Richard G. B.
Reich, Kristian
Strand, Vibeke
Feldman, Steven R.
Paul, Carle
Gordon, Kenneth
Warren, Richard B.
Toth, Darryl
Nikaï, Enkeleida
Zhu, Baojin
Goldblum, Orin
Edson-Heredia, Emily
Carlier, Hilde
Burge, Russel
Lin, Chen-Yen
Hollister, Kristin
Augustin, Matthias
-
Źródło:
-
Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation - An Official Journal of the International Society of Quality of Life Research. 29(2):369-380
-
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.